title: [Myoadenylate deaminase deficiency among patients with myasthenia gravis--preliminary results of exercise].
abstract: Myasthenia Gravis (MG) is a primary disorder of neuromuscular transmission, and patients suffering from this disease manifest specific, progressive weakness of several groups of skeletal muscles. Myoadenylate deaminase deficiency (MADD) is an inborn disease of skeletal muscles, the clinical symptoms of which may mimic symptoms observed in MG. Preliminary results of studies presented in this paper suggest that simultaneous occurrence of MG and MADD may modify energetic metabolism of skeletal muscle.
authors.affiliation: Katedra i Klinika Neurologii Dorosłych Akademii Medycznej w Gdańsku.
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Bilińska
authors.forename: Zygmunt
authors.initials: Z
authors.lastname: Chodorowski
authors.forename: Walenty
authors.initials: W
authors.lastname: Nyka
authors.forename: Wiesława
authors.initials: W
authors.lastname: Nyka
authors.forename: Iwona
authors.initials: I
authors.lastname: Rybakowska
authors.forename: Ryszard
authors.initials: R
authors.lastname: Smoleński
authors.forename: Krystian
authors.initials: K
authors.lastname: Kaletha
mesh_terms: D000659:AMP Deaminase / Q000172:deficiency*; D000293:Adolescent; D000328:Adult; D015444:Exercise; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D018482:Muscle, Skeletal / Q000201:enzymology* / Q000473:pathology; D009157:Myasthenia Gravis / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology; D009468:Neuromuscular Diseases / Q000201:enzymology
chemical_list: D000659:AMP Deaminase